Genprex, Inc.
Key Metrics
Market Snapshot
About
Genprex, Inc. is a clinical-stage biopharmaceutical company developing targeted gene therapies for cancer and diabetes. The company's lead oncology candidate Reqorsa is a tumor suppressor gene therapy delivered through a proprietary nanoparticle delivery system for treatment of non-small cell lung cancer. Genprex is also developing Oncoprex immunogene therapy and diabetes treatment GPX-002 using its TUSC2 nanoparticle technology platform. The company's approach focuses on delivering therapeutic genes directly to diseased tissues while minimizing systemic exposure.